TCM
Traynor Capital Management Portfolio holdings
AUM
$1.41B
1-Year Return
21.96%
This Quarter Return
+13.84%
1 Year Return
+21.96%
3 Year Return
+180.31%
5 Year Return
+256.34%
10 Year Return
+705.73%
AUM
$845M
AUM Growth
+$115M
(+16%)
Cap. Flow
+$32.2M
Cap. Flow
% of AUM
3.81%
Top 10 Holdings %
Top 10 Hldgs %
52.31%
Holding
236
New
36
Increased
90
Reduced
74
Closed
13
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
$8.47M |
| 2 |
Vale
VALE
|
$4.22M |
| 3 |
Apple
AAPL
|
$3.89M |
| 4 |
Amazon
AMZN
|
$3.59M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$3.1M |
Top Sells
| 1 |
Biogen
BIIB
|
$6.43M |
| 2 |
CRISPR Therapeutics
CRSP
|
$2.93M |
| 3 |
iShares S&P 500 Value ETF
IVE
|
$2.56M |
| 4 |
Boeing
BA
|
$1.64M |
| 5 |
QuidelOrtho
QDEL
|
$1.17M |
Sector Composition
| 1 | Technology | 28.29% |
| 2 | Consumer Discretionary | 14.66% |
| 3 | Communication Services | 13.06% |
| 4 | Healthcare | 6.45% |
| 5 | Financials | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
226
Biogen
BIIB
$20.3B
| – | – |
-22,730
| Closed | -$6.43M |
|
|
227
CRISPR Therapeutics
CRSP
$4.75B
| – | – |
-26,195
| Closed | -$2.93M |
|
228
Crexendo
CXDO
$191M
| $0 | ﹤0.01% |
+44,772
| New | – |
|
229
Iovance Biotherapeutics
IOVA
$782M
| – | – |
-10,115
| Closed | -$249K |
|
230
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
$408M
| – | – |
-12,027
| Closed | -$177K |
|
|
PNNT
231
Pennant Park Investment Corp
PNNT
$471M
| – | – |
-11,400
| Closed | -$73K |
|
232
Real Brokerage
REAX
$1.1B
| – | – |
-30,000
| Closed | -$55K |
|
233
SPDR Portfolio S&P 500 ETF
SPLG
$83.6B
| – | – |
-13,348
| Closed | -$673K |
|
234
Teladoc Health
TDOC
$1.34B
| – | – |
-3,031
| Closed | -$384K |
|
235
Zhongchao
ZCMD
$24.8M
| – | – |
-1,010
| Closed | -$16K |
|